Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H2M in Acute Ischemic Stroke
NCT03320018Phase 3Completed
- Sponsor
- Stony Brook University
- Start
- Aug 2017
- Primary completion
- Aug 2019
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Molecular hydrogen, minocycline in ischemic stroke, sponsored by Stony Brook University. Started Aug 2017; status: completed.
02
Drugs
Molecular hydrogenminocycline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03320018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320018.